SynthesisMedicina (Kaunas, Lithuania)2022

EGFR Tyrosine Kinase Inhibitor Efficacy in Older Adult Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer: A Meta-Analysis and Systematic Review.

Chang-Hung Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.